Zeno Equity Partners LLP Has $39.50 Million Position in Danaher Corporation $DHR

Key Points

• Zeno Equity Partners LLP increased its stake in Danaher Corporation by 10.7%, now holding 192,450 shares worth approximately $39.5 million, making it the firm's second largest position.
• Several institutional investors have also raised their positions in Danaher, with Bank Pictet & Cie Europe AG increasing its stake by 22.8% in the last quarter.
• Danaher Corporation reported earnings of $1.80 per share for the latest quarter, exceeding estimates, and its revenue rose 3.4% year-over-year.

Zeno Equity Partners LLP grew its stake in shares of Danaher Corporation (NYSE:DHR - Free Report) by 10.7% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 192,450 shares of the conglomerate's stock after buying an additional 18,585 shares during the quarter. Danaher accounts for 13.5% of Zeno Equity Partners LLP's investment portfolio, making the stock its 2nd biggest position. Zeno Equity Partners LLP's holdings in Danaher were worth $39,496,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Bank Pictet & Cie Europe AG raised its position in Danaher by 22.8% in the 4th quarter. Bank Pictet & Cie Europe AG now owns 192,731 shares of the conglomerate's stock worth $44,241,000 after purchasing an additional 35,730 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Danaher by 7.4% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 63,534 shares of the conglomerate's stock worth $14,584,000 after purchasing an additional 4,388 shares during the period. Minot DeBlois Advisors LLC purchased a new position in Danaher in the 4th quarter worth $1,606,000. Obermeyer Wealth Partners raised its position in Danaher by 25.6% in the 4th quarter. Obermeyer Wealth Partners now owns 2,012 shares of the conglomerate's stock worth $462,000 after purchasing an additional 410 shares during the period. Finally, OMERS ADMINISTRATION Corp raised its position in Danaher by 74.3% in the 4th quarter. OMERS ADMINISTRATION Corp now owns 50,202 shares of the conglomerate's stock worth $11,524,000 after purchasing an additional 21,397 shares during the period. Hedge funds and other institutional investors own 79.05% of the company's stock.

Danaher Stock Performance

DHR opened at $198.74 on Tuesday. The firm has a market cap of $142.31 billion, a P/E ratio of 42.29, a PEG ratio of 2.79 and a beta of 0.75. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $279.90. The company has a 50 day simple moving average of $201.95 and a two-hundred day simple moving average of $199.23. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. The business had revenue of $5.94 billion during the quarter, compared to analyst estimates of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company's revenue was up 3.4% on a year-over-year basis. During the same period in the prior year, the business posted $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Insider Buying and Selling at Danaher

In related news, Director Teri List sold 2,778 shares of the company's stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the transaction, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 11.20% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on DHR. Wall Street Zen upgraded shares of Danaher from a "hold" rating to a "buy" rating in a research report on Friday, June 27th. Deutsche Bank Aktiengesellschaft decreased their target price on shares of Danaher from $240.00 to $235.00 in a research report on Thursday, June 5th. Royal Bank Of Canada set a $241.00 target price on shares of Danaher in a research report on Tuesday, September 2nd. Wells Fargo & Company decreased their price objective on shares of Danaher from $210.00 to $205.00 and set an "equal weight" rating on the stock in a research report on Wednesday, July 23rd. Finally, Barclays restated an "overweight" rating and issued a $225.00 price objective (up previously from $215.00) on shares of Danaher in a research report on Tuesday, June 24th. Seventeen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $246.35.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.